help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamson-Reig, A.
Right arrow Articles by Lux-Lantos, V. A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamson-Reig, A.
Right arrow Articles by Lux-Lantos, V. A. R.
Endocrinology Vol. 140, No. 8 3573-3580
Copyright © 1999 by The Endocrine Society

ARTICLES

Alterations in Intracellular Messengers Mobilized by Gonadotropin-Releasing Hormone in an Experimental Ovarian Tumor1

Astrid Chamson-Reig, Omar P. Pignataro, Carlos Libertun and Victoria A. R. Lux-Lantos

Instituto de Biología y Medicina Experimental-CONICET, 1428 Buenos Aires, Argentina

Address all correspondence and requests for reprints to: Dr. Carlos Libertun, Instituto de Biología y Medicina Experimental, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina. E-mail: libertun{at}dna.uba.ar

Cells derived from an experimental luteinized ovarian tumor are more sensitive to GnRH endocrine action than control luteal cells. In an attempt to understand the possible causes of the differential sensibility to GnRH action, we examined the number and affinity of GnRH receptors and the second messenger response to GnRH stimulation in both tissues. For GnRH receptor studies membranes were obtained from 4- to 6-week-old ovarian tumors (luteoma) and ovaries from prepubertal rats treated with 25 IU PMSG and 25 IU hCG (SPO) and were incubated with [125I]Buserelin. The number of GnRH receptors were increased in luteoma compared with that in SPO ovaries; dissociation constants were similar in both tissues. GnRH stimulation of second messenger release was assessed in cells obtained from luteoma and SPO ovaries by collagenase treatment. Buserelin (100 ng/ml) induced a significant 35% calcium increase in SPO cells, as determined by the fura-2 method; in luteoma cells no response was observed after buserelin stimulation, although a calcium transient was induced by thapsigargin (0.5 µM), an inhibitor of Ca2+-adenosine triphosphatase associated with the endoplasmic reticulum. The effect of buserelin on inositol phosphates was evaluated after incubation of luteoma and SPO cells with [3H]myo-inositol for 48 h. Buserelin induced a 400% increase in inositol trisphosphate in SPO cells. Again, luteoma cells did not respond to buserelin stimulation, although NaF (10 mM), an activator of G proteins coupled to phospholipase C, induced an 800% increase in inositol trisphosphate. Although the number of GnRH receptors is augmented in luteoma cells, justifying an increased endocrine response, neither inositol phosphates nor intracellular calcium were released by a GnRH analog, indicating the uncoupling of GnRH receptors from phospholipase C. These data provide evidence that the transformation of the ovary into a luteoma implies the acquisition of novel characteristics in the GnRH receptor second messenger-generating system.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Irusta, F. Parborell, and M. Tesone
Inhibition of cytochrome P-450 C17 enzyme by a GnRH agonist in ovarian follicles from gonadotropin-stimulated rats
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1456 - E1464.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
L. A. Mongiat, V. A. Lux-Lantos, and C. Libertun
Evidence for Different Gonadotropin-Releasing Hormone Response Sites in Rat Ovarian and Pituitary Cells
Biol Reprod, August 1, 2004; 71(2): 464 - 469.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Chamson-Reig, E. M. Sorianello, P. N. Catalano, M. O. Fernandez, O. P. Pignataro, C. Libertun, and V. A. R. Lux-Lantos
Gonadotropin-Releasing Hormone Signaling Pathways in an Experimental Ovarian Tumor
Endocrinology, July 1, 2003; 144(7): 2957 - 2966.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
G. Irusta, F. Parborell, M. Peluffo, P. R. Manna, S. I. Gonzalez-Calvar, R. Calandra, D. M. Stocco, and M. Tesone
Steroidogenic Acute Regulatory Protein in Ovarian Follicles of Gonadotropin-Stimulated Rats Is Regulated by a Gonadotropin-Releasing Hormone Agonist
Biol Reprod, May 1, 2003; 68(5): 1577 - 1583.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
F. Parborell, A. Pecci, O. Gonzalez, A. Vitale, and M. Tesone
Effects of a Gonadotropin-Releasing Hormone Agonist on Rat Ovarian Follicle Apoptosis: Regulation by Epidermal Growth Factor and the Expression of Bcl-2-Related Genes
Biol Reprod, August 1, 2002; 67(2): 481 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C.-H. Chiang, K. W. Cheng, S. Igarashi, P. S. Nathwani, and P. C. K. Leung
Hormonal Regulation of Estrogen Receptor {alpha} and {beta} Gene Expression in Human Granulosa-Luteal Cells in Vitro
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3828 - 3839.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society